0.00Open0.05Pre Close0 Volume44 Open Interest78.00Strike Price0.00Turnover757.64%IV2.09%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0701Delta0.0840Gamma1592.20Leverage Ratio-41.2875Theta0.0000Rho-111.60Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet